Answers are grounded in this paper and cite their sources.
This research highlights the role of genetic mutations in cancer treatments, suggesting broader drug applications beyond histology.
Cancer treatment is primarily based on histological examination and related to the organ in which it develops (e.g. colon adenocarcinoma or squamous cell carcinoma of the lung). While this is a starting point, it cannot be considered the sole basis for treatment. The discovery of genetic mutations in neoplastic cells, whether somatic or germline, is a valuable aid in the development of innovative drugs. These drugs can be used regardless of the organ, facilitating clinical research and application.
No takes yet. Share an insight, caveat, or question.
Massimo Bonucci (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: